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Abstract
Background: To evaluate the predictive value of analytical markers of full blood count that can be assessed in the
emergency department for HIV infected patients, with community-acquired pneumonia (CAP).
Methods: Prospective 3-year study including all HIV-infected patients that went to our emergency department with
respiratory clinical infection, more than 24-h earlier they were diagnosed with CAP and required admission. We
assessed the different values of the first blood count performed on the patient as follows; total white blood cells
(WBC), neutrophils, lymphocytes (LYM), basophils, eosinophils (EOS), red blood cells (RBC), hemoglobin, hematocrit,
mean corpuscular volume, mean corpuscular hemoglobin concentration, mean corpuscular hemoglobin, red blood cell
distribution width (RDW), platelets (PLT), mean platelet volume, and platelet distribution width (PDW). The primary
outcome measure was 30-day mortality and the secondary, admission to an intensive care unit (ICU). The predictive
power of the variables was determined by statistical calculation.
Results: One hundred sixty HIV-infected patients with pneumonia were identified. The mean age was 42 (11) years,
99 (62%) were male, 79 (49%) had ART. The main route of HIV transmission was through parenteral administration of
drugs. Streptococcus pneumonia was the most frequently identified etiologic agent of CAP The univariate analysis
showed that the values of PLT (p < 0.009), EOS (p < 0.033), RDW (p < 0.033) and PDW (p < 0.09) were predictor of
mortality, but after the logistic regression analysis, no variable was shown as an independent predictor of mortality. On
the other hand, higher RDW (OR = 1.2, 95% CI 1.1-1.4, p = 0.013) and a lower number of LYM (OR 2.2, 95% CI 1.1-2.2;
p = 0.035) were revealed as independent predictors of admission to ICU.
Conclusion: Red blood cell distribution and lymphocytes were the most useful predictors of disease severity identifying
HIV infected patients with CAP who required ICU admission.
Background
Community-acquired pneumonia (CAP) is the most com-
mon infection affecting HIV infected patients presenting
to the Emergency Department (ED) [1], and one of the
major causes of death due to infectious aetiology, as well
as in the general population [2]. Among the HIV infected
patients, the highly active antiretroviral therapy (ART) has
the most consistent effect on reducing pneumonia and in
the patients with fewer than CD4 count 200 cells / μl,
antimicrobial prophylaxis is usually effective [3]. The
identification or recognition of biomarkers rapidly ob-
tained together with clinical scores and guidelines [4, 5],
having allowed us to predict the severity of the HIV in-
fected patients with CAP, would help us to optimize treat-
ment and its management. The blood count is a
laboratory test, done to any patient who visits an Emer-
gency Department (ED) with an infectious clinic of any
aetiology. These results are obtained quickly.
A number of biochemical and haematological markers
have been used to assess systemic inflammation or infec-
tion as pneumonia in the clinical setting, in the develop
countries. Particularly C-reactive protein levels, erythro-
cyte sedimentation rate, white blood cell counts, haemo-
globin levels, and procalcitonin levels [6], which have an
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important value in predicting outcomes in severe infec-
tions [7–9]. Most of the biomarker studies are per-
formed in the general population whereas in the HIV-
infected population, the studies done with biomarkers
are generally not immediately available, such as interleu-
kins [10], or in patients with opportunistic infections
[11, 12]. Some of them, showed that some values or the
full blood count, as haemoglobin and CD4 count, were
predictors of poor outcome [13], but they do not make
specific reference of CAP.
Therefore, our group evaluated the prognosis of HIV-
infected patients diagnosed with CAP based on blood
count values, since their results are obtained quickly and
can be useful in the management of this pathology.
Methods
Patients
This is a prospective three-years (2011-2013) at a large
university hospital caring for HIV-infected patients in
Barcelona, Spain. It included all the HIV infected pa-
tients that attended our ED with respiratory clinical his-
tory of more than 24 h of evolution and were diagnosed
with CAP and required admission. Patients with high
suspicion of P. jirovecii and/or tuberculosis on the basis
of clinical and radiological presentation, plasma lactate
dehydrogenase levels and/or Ziehl sputum staining,
those who had received antibiotic treatment during the
last 7 days, required hospitalization within the previous
15 days and patients from other hospitals were not in-
cluded in this study.
Definitions
The CAP was defined according to the criteria of the In-
fectious Disease Society of America (IDSA) [14], that in-
clude radiographic criteria (pulmonary condensation,
cough, fever, among others. It diagnostic was made at
ED. The intensive care unit (ICU) admission criteria at
our center are based on the IDSA / ATS recommenda-
tions [15]. Patient with severe immunosuppression was
defined as having a CD4 count < 350 cells/μl.
Variables
For the purpose of this study, the following epidemio-
logical, clinical and laboratory variables were collected:
gender, age, previous number of CD4 lymphocytes, and
viral load (VL) prior to admission, treatment with ART,
co-infection with hepatitis C virus. Values of the full
blood count (no longer than 2 h after presentation to
ED the blood test was drawn), such as total white blood
cells (WBC), neutrophils, absolute lymphocytes (LYM),
basophils, eosinophils (EOS), red blood cells (RBC),
hemoglobin, hematocrit, mean corpuscular volume,
mean corpuscular hemoglobin concentration, mean cor-
puscular hemoglobin, Red blood cell distribution width
(RDW), platelets (PLT), mean platelet volume, and plate-
let distribution width (PDW) (the values of measure
units and normality intervals in our center can be seen
in Additional file 1), the score of APACHE II scale, sys-
tolic blood pressure, heart rate, respiratory rate and ar-
terial oxygen pressure, and C-reactive protein on the
arrival to our ED. In addition, admission to an ICU and
30-days mortality were analysed.
Laboratory studies
In order to obtain a microbiological diagnosis, a naso-
pharyngeal swab to detect respiratory viruses was used
(Viral Culturette, Direct, Becton-Dickinson Microbiol-
ogy Systems, MD, USA), urinary antigens to identify
Streptococcus pneumoniae (BinaxNOW S. pneumoniae
Urinary Antigen Test, USA) and Legionella pneumophila
(BinaxNOW Legionella Urinary Antigen Test, USA) in
concentrated urine in advance, and two blood cultures
(Bactec 9240; Becton Dickinson, USA) before adminis-
tering the antibiotic were performed. A sputum sample
was collected for Gram stain and culture when the pa-
tient could expectorate before administration of the
antibiotic.
To assess the severity of the condition, the APACHE
II score was used (as previously studies) [16] because
FINE scale [17], which is regularly used, is not standard-
ized to use for immunosuppressed population.
End- points
The primary end-point was, that full blood counts
values, can predict 30-day mortality, related with CAP.
Patients were followed by telephone during 3 months.
The second end-point was that full blood counts
values, can predict ICU admission during hospitalization
related with CAP.
Statistical analysis
As for the statistical calculations, the categorical variables
were expressed as frequencies and percentages, and the
continuous variables were expressed as mean and stand-
ard deviation. Factors associated with ICU admission and
mortality were assessed by univariate and multivariate
analyses. Results were considered statistically significant
when P was less than 0.05. For independent samples, Stu-
dent’s t-test was used to evaluate continuous variables and
the chi-squared test was selected to evaluate categorical
variables. All statistical analyses were calculated by SPSS
version 20.0 (Chicago, IL, USA).
Results
One hundred sixty HIV-infected patients diagnosed with
CAP were included to this study. The median age (IQR)
was 42 (11) years, 99 (62%) were males, 79 (49%) were
under ART, 9 (6%) were unaware of their HIV infection
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and their diagnosis was held in the same ED. The median
(IQR) total CD4 count was 240 (405) cells/μl, and the viral
load in blood was 815 (40,331) RNA copies/mm3. There
was HCV co-infection in 95 (60%) patients. The main
route of HIV infection was the use of parenteral drugs.
The remaining variables can be seen in Table 1.
A bacterial diagnosis was confirmed in 90 (60%) pa-
tients. The most commonly diagnosed bacterium was S.
pneumoniae in 81 (51%) patients, and no microbiological
diagnosis was obtained in 70 (49%). Blood culture, Gram
stain and culture, urinary antigen were positive in 34
(21%), 32 (21%) and 52 (33%) patients for S. pneumo-
niae, respectively. The Gram stain was positive in 14 pa-
tients, while in the other 20, was the cultured necessary
to get the diagnosis. Respiratory viruses were isolated in
14 patients, being rhinovirus as the most frequently iso-
lated respiratory virus in 6 (4%) patients (Table 2).
Forty patients required admission to an ICU (25%),
and 21 (13%) required mechanic ventilation. Patients
who died were 9 (6%) patients, and all died in the ICU.
In the nine patients who died during their hospital stay,
S. pneumoniae was the bacterium detected in most occa-
sions (6 cases), 1in the sputum culture, 3 in the urinary
antigen and in 2 in the blood culture. In two patients,
no microbiological diagnosis was acquired, and in one
case, the rhinovirus was found as the only microorgan-
ism. The variables (Table 3), assessed in the univariate
analysis were only the blood count, and showed that
mortality group had significant lower values of PLT
(112.7+/− 57.6 vs. 196.55+/− 102.6; p < 0.009) and EOS
(0.044+/− 0.039 vs. 0.108+/− 0.138; p < 0.033), and higher
values of RDW (17.2+/− 2.9 vs. 15.3+/− 2.4; p < 0.033)
and PDW (20.6+/− 5.0 vs. 17.5+/− 10.7; p < 0.09). Direct
logistic regression was performed to asses full blood
counts variables that can predict mortality or ICU ad-
mission. The variables included in the model were PLT,
EOS, LYM, PDW and RDW. No other variables were in-
cluded in the model. The full models containing all pre-
dictors were statistically significant in both cases
(mortality: chi-square = 13.4; p = 0.009; ICU: chi-square
= 14.0; p = 0.016), however none of the analysed vari-
ables were evaluated as an independent predictor of
mortality. On the other hand, a higher RDW (OR = 1.2,
95% CI 1.1-1.4; p = 0.013) and a lower number of LYM
(OR 2.2, 95% CI 1.1-2.2; p = 0.035) were shown as inde-
pendent predictors of ICU admission. The rest of the
analysed variables were not predictive factors of poor
outcome.
There were no statistically significant differences
among the patients who had a microbiological diagnosis,
those who did not have any, and those who presented
severe immunosuppression (p > 0.05). Patients with sev-
eral immunosuppression diagnoses didn’t present signifi-
cant mortality (p > 0.05), the CD4 counts it’s not
statistically different between both groups in the univari-
ate analysis so the CD4 counts not seems to be the rea-
son for this relationship.
On the other hand, a higher RDW (OR = 1.2, 95% CI
1.1-1.4; p = 0.013) and a lower number of LYM (OR 2.2,
95% CI 1.1-2.2; p = 0.035) were shown as independent
predictors of ICU admission.
Discussion
We hypothesized that the different values of full blood
count can predict pneumonia outcome in HIV-infected
patients, but statistic analysis showed opposite results
Table 1 Clinical and analytical characteristics of the 160 patients included in the study
Total cohort No ICU ICU
Age (IQRa) 42 (11) 43 (11) 41 (12)
Gender (male%) 99 (62%) 74 (67%) 25 (63%)
Total CD4 (cells/mm3) (median (IQR)) 242 (406) 350 (102) 247 (359)
Viral load in blood (copies RNA/mm3) (median (IQR)) 709 (39961) 702 (36631) 5200 (111000)
Undetectable viral load < 200 copies/mL (n (%)b) 62 (39%) 50 12
Parental drug abuse as a risk factor for HIV (n (%)) 94 (59%) 24 70
ART (n (%)) 78 (49%) 61 (51%) 18 (45%)
APACHE II Scale Score (mean (IQR)) 14 (7) 10 (6) 16 (7)
Heart rate (median (IQR)) 96 (24) 94 (31) 97 (22)
Respiratory rate (median(IQR)) 22 (8) 20 (6) 26 (11)
Partial pressure of oxygen in blood (mmHg) (mean (IQR)) 60 (16) 65 (20) 55 (12)
HCV Co-Infection (n (%)) 94 (59%) 34 60
Blood leukocytes (cells/mm3) (mean (IQR)) 9 (7) 9 (7) 12 (11)
C-reactive protein (mg/dl) (mean (IQR)) 14 (21) 13 (18) 19 (23)
aIQR: interquartile range
bUndetectable viral load: HIV viral load in blodd < 200 copies/mL
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according the primary end-point. We studied the value
of the blood count as it is rapidly and widely available at
relatively. For its interpretation of results it must be
taken into account that in the HIV-infected patient
anemia, leukopenia, and thrombocytopenia are the most
common hematological abnormalities resulting from
HIV infection [18].
HIV infection is associated with chronic inflammation
and an increased risk of thrombotic events so that plate-
let indices may offer a rapid and affordable method to
monitor platelet activation and disease progression in
patients with HIV [19, 20]. Platelet aggregation plays a
crucial role in the immune defense mechanism against
viruses and bacterial LPS and subsequently forming
platelet leukocyte aggregate. It is known that platelet
monocyte aggregation correlates with markers of im-
mune activation, disease progression and platelet aggre-
gation in HIV treatment [21]. But despite the important
role they play in the entire infectious process, and in
sepsis-associated coagulopathy [22], in our study neither
the PLT value nor the PDW value showed a predictive
value of poor prognosis.
As for the WBC value, our study utilized both the fre-
quency of EOS and total LYM and compared count of
EOS with previous studies. These results were in accord-
ance with the same ones performed by our group
previously [23], which showed that they were not a fac-
tor of poor prognosis, in terms of mortality. LYM can
generate more discussion, since they depend on many
variables and not always from HIV, and a high level of
LYM does not means a better immune state. Bordon et
al. [24] showed that total CD4, CV and ART variables
were not a predictor of poor prognosis in HIV infected
patients with CAP. These results coincide with our
study, so we believe that our study still provides further
evidence on this subject. LYM only showed predictors
markers of ICU admission. We know that this affirm-
ation could be a point of intensive discussion, because
several studies showed on the contrary [25] maybe by
the methodology used, but several meta-analysis must
be done in this subject.
As the RBC, is known, that ART can alter many haem-
atological figures. Therefore, diagnosis of thalassaemia,
anisocytosis and anemia should be evaluated carefully in
combination with those parameters [26]. Anemia is an
important marker of uncontrolled HIV infection [27],
and in non-HIV infected patients with pneumonia it is
an independent predict risk factor [28].
One of the most important RBC markers is probably
RWD, which remains a powerful marker of cardiovascu-
lar disease [29]. However, our study showed no predict-
ive value for mortality like the study by Braun et al. [30],
in which RDW elevation was associated with higher
morbidity and mortality while it was performed in the
general population. RDW was predictor as LYM of ICU
admission.
Respiratory failure remains the highest cause of ICU
admission in HIV infected patients, accounting for 25 to
40% of the admissions [31], neutrophil-to-lymphocyte
ratio is a good predictor for ICU admission in elderly
no-HIV adults with CAP [32].
Nowadays, using medicine in which high technology is
widely established, the collection of vital signs in the
same head of the patient, a good medical history and
physical examination, combined with a calculation of a
severity score and a series of laboratory values at an af-
fordable cost, could be sufficient to predict the prognosis
of CAP in HIV infected patients, and identify those that
require more complex management, without relying on
other more expensive tests.
Limitations
Our study has been implemented in a single hospital
center, although it was with an important sample to ob-
tain conclusions. This study could have a serious bias
since only those who required hospitalization were in-
cluded. CAPs caused by opportunistic microorganisms
have not been included. Moreover, pneumococcal and/
or influenza vaccination variables have not been in-
cluded, either. Another limitation was that HIV positive
Table 3 Logistic regression
Mortality ICU Admission
OR (IC 95%) P OR (IC 95%) P
PLT (109/L) 0.99 (0.98 – 1.00) 0.069 1.00 (0.99 – 1.00) 0.933
EOS (%) 0.00 (0.00 – 41.22) 0.128 1.42 (0.06 – 35.49) 0.830
RDW (%) 1.30 (0.97 – 1.73) 0.080 1.21 (1.04 – 1.41) 0.013
PDW (%) 1.02 (0.95 – 1.09) 0.643 0.99 (0.96 – 1.04) 0.864
LYM (%) 1.37 (0.53 – 3.55) 0.516 0.45 (0.22 - 0.95 0.035
PLT Platelets, EOS Eosinophils, RDW Red blood cell distribution width, PDW
Platelet distribution width, LYM Lymphocytes. Units: (109cells/L)











Influenza A Virus 2(1%)
Influenza B Virus 1(1%)
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population mostly acquired HIV infection through IV
drug use, and had relatively low levels of virological sup-
pression and relatively low CD4 counts. Given this small
number patients with the outcome, it would be difficult to
detect a significant finding with multivariable analysis
even if blood counts were truly associated with prognosis.
The small number of outcomes was another limitation.
Conclusion
In HIV infected patients with CAP, an increase in RDW
and a decrease in the number of absolute LYM were
shown to be independent predictors of ICU admission.
Although no statistically significant associations were
observed between blood counts and mortality, numbers
were too small to draw firm conclusions.
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